Target intelligence / Profile preview

RNA, U4 small nuclear 24, pseudogene (RNU4-24P)

Target: RNU4-24P
Molecular classification: Other (Pseudogene), Non-coding RNA pseudogene

Overview

RNU4-24P is annotated as a pseudogene related to the U4 small nuclear RNA (snRNA) family[1]. Pseudogenes are non-functional copies or remnants of active genes; in this case, RNU4-24P does not code for a functional RNA and is not known to produce a functional protein or RNA product. Its parent gene family (U4 snRNA) is involved in pre-mRNA splicing as part of the spliceosome, but RNU4-24P itself has no validated biological activity or disease association. It is not a therapeutic target, nor does it have known interacting drugs, disease roles, or recognized biomarker utility. Its presence in genomic databases is for reference, not function.

Other names: RNU4-24PU4 snRNA pseudogene 24

Beyond the preview

Go deeper on RNA, U4 small nuclear 24, pseudogene (RNU4-24P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 24, pseudogene (RNU4-24P).

Explore the full profile